News | December 10, 2023
Aptar Pharms opens new production facility at Taloja, Mumbai
New facility is part of Aptar Pharma’s global expansion program
New facility is part of Aptar Pharma’s global expansion program
First published clinical trial using live biotherapeutic candidate in Covid-19 patients suggests role in improving outcomes
This acquisition marks Max Healthcare's entry into Lucknow
There has been no loss or injury to human life
Conditional marketing authorization is based on clinically meaningful response rates, duration of response, and safety from the Phase 2 MagnetisMM-3 trial
Approximately 16,000 patients 12 years of age and older with severe sickle cell disease may now be eligible for this one-time treatment
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
Venus Remedies is supplying the drug to many countries like Colombia, Thailand, Tanzania, Morocco, Myanmar, Indonesia, Saudi Arabia, Malaysia, Zimbabwe, Sri Lanka, Pakistan, Kenya, and Botswana
The esteemed duo perfectly embody the brand's core values of family, love, and the special bond we share with our pets
The acquisition will enable Cupid Limited to amplify its production capacity by 1.5 times the existing output
Subscribe To Our Newsletter & Stay Updated
